156 related articles for article (PubMed ID: 28314512)
21. Synthesis and Pharmacological Evaluation of Enantiopure N-Substituted Ortho-c Oxide-Bridged 5-Phenylmorphans.
Li F; Kopajtic TA; Katz JL; Luo D; Prisinzano TE; Imler GH; Deschamps JR; Jacobson AE; Rice KC
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557961
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors.
Zhang B; Zhang T; Sromek AW; Scrimale T; Bidlack JM; Neumeyer JL
Bioorg Med Chem; 2011 May; 19(9):2808-16. PubMed ID: 21482470
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, pharmacological evaluation and molecular dynamics of β-amino acids morphan-derivatives as novel ligands for opioid receptors.
Nieto CT; Gonzalez-Nunez V; Rodríguez RE; Diez D; Garrido NM
Eur J Med Chem; 2015 Aug; 101():150-62. PubMed ID: 26134550
[TBL] [Abstract][Full Text] [Related]
24. Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.
Ananthan S; Khare NK; Saini SK; Davis P; Dersch CM; Porreca F; Rothman RB
Bioorg Med Chem; 2003 Sep; 11(18):4143-54. PubMed ID: 12927876
[TBL] [Abstract][Full Text] [Related]
25. In-vitro investigation of oxazol and urea analogues of morphinan at opioid receptors.
Peng X; Knapp BI; Bidlack JM; Neumeyer JL
Bioorg Med Chem; 2007 Jun; 15(12):4106-12. PubMed ID: 17433695
[TBL] [Abstract][Full Text] [Related]
26. 4β-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4β-methyl-5-(3-hydroxyphenyl)morphan pure antagonist.
Carroll FI; Gichinga MG; Williams JD; Vardy E; Roth BL; Mascarella SW; Thomas JB; Navarro HA
J Med Chem; 2013 Nov; 56(21):8826-33. PubMed ID: 24144404
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
Seki T; Awamura S; Kimura C; Ide S; Sakano K; Minami M; Nagase H; Satoh M
Eur J Pharmacol; 1999 Jul; 376(1-2):159-67. PubMed ID: 10440101
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence.
Neumeyer JL; Bidlack JM; Zong R; Bakthavachalam V; Gao P; Cohen DJ; Negus SS; Mello NK
J Med Chem; 2000 Jan; 43(1):114-22. PubMed ID: 10633042
[TBL] [Abstract][Full Text] [Related]
30. Univalent and bivalent ligands of butorphan: characteristics of the linking chain determine the affinity and potency of such opioid ligands.
Decker M; Fulton BS; Zhang B; Knapp BI; Bidlack JM; Neumeyer JL
J Med Chem; 2009 Dec; 52(23):7389-96. PubMed ID: 19634902
[TBL] [Abstract][Full Text] [Related]
31. High-affinity carbamate analogues of morphinan at opioid receptors.
Peng X; Knapp BI; Bidlack JM; Neumeyer JL
Bioorg Med Chem Lett; 2007 Mar; 17(6):1508-11. PubMed ID: 17276685
[TBL] [Abstract][Full Text] [Related]
32. Phenylmorphans and analogues: opioid receptor subtype selectivity and effect of conformation on activity.
Froimowitz M; Pick CG; Pasternak GW
J Med Chem; 1992 May; 35(9):1521-5. PubMed ID: 1315868
[TBL] [Abstract][Full Text] [Related]
33. High affinity [3H]ethylketazocine binding: evidence for specific kappa receptors.
Wood PL; Charleson S
Neuropharmacology; 1982 Mar; 21(3):215-9. PubMed ID: 6122185
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and opioid receptor activity of indolopropellanes.
Li F; Gaob L; Yin C; Chen J; Liu J; Xie X; Zhang A
Bioorg Med Chem Lett; 2009 Aug; 19(16):4603-6. PubMed ID: 19595591
[TBL] [Abstract][Full Text] [Related]
35. Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan.
Neumeyer JL; Gu XH; van Vliet LA; DeNunzio NJ; Rusovici DE; Cohen DJ; Negus SS; Mello NK; Bidlack JM
Bioorg Med Chem Lett; 2001 Oct; 11(20):2735-40. PubMed ID: 11591513
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.
Spetea M; Schüllner F; Moisa RC; Berzetei-Gurske IP; Schraml B; Dörfler C; Aceto MD; Harris LS; Coop A; Schmidhammer H
J Med Chem; 2004 Jun; 47(12):3242-7. PubMed ID: 15163203
[TBL] [Abstract][Full Text] [Related]
37. Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4'-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptors.
Huang B; Gunta R; Wang H; Li M; Cao D; Mendez RE; Gillespie JC; Chen C; Huang LM; Liu-Chen LY; Selley DE; Zhang Y
Bioorg Chem; 2021 Apr; 109():104702. PubMed ID: 33631465
[TBL] [Abstract][Full Text] [Related]
38. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
[TBL] [Abstract][Full Text] [Related]
39. Chemistry of opium alkaloids. Part 44: synthesis and opioid receptor binding profile of substituted ethenoisomorphinans and ethenomorphinans.
Maat L; Woudenberg RH; Meuzelaar GJ; Linders JT
Bioorg Med Chem; 1999 Mar; 7(3):529-41. PubMed ID: 10220038
[TBL] [Abstract][Full Text] [Related]
40. Probes for narcotic receptor mediated phenomena. 43. Synthesis of the ortho-a and para-a, and improved synthesis and optical resolution of the ortho-b and para-b oxide-bridged phenylmorphans: compounds with moderate to low opioid-receptor affinity.
Li F; Folk JE; Cheng K; Kurimura M; Deck JA; Deschamps JR; Rothman RB; Dersch CM; Jacobson AE; Rice KC
Bioorg Med Chem; 2011 Jul; 19(14):4330-7. PubMed ID: 21684752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
